Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01731184Phase 3Completed
Phase 3, randomised, double-blind trial in acute pain comparing Midazolam + Morphine with Placebo + Morphine (2 arms). Primary endpoint: Proportion of patients with a pain score less than or equal to 3. Started Nov 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01731184.